Home Applications 219666 Application 219666
Type NDA
Sponsor PTC THERAP Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 SEPHIENCE SEPIAPTERIN POWDER;ORAL 250MG/PACKET Yes No 002 SEPHIENCE SEPIAPTERIN POWDER;ORAL 1GM/PACKET Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219666-001 SEPHIENCE SEPIAPTERIN 250MG/PACKET POWDER / ORAL RLD 2025-07-28 N219666-002 SEPHIENCE SEPIAPTERIN 1GM/PACKET POWDER / ORAL RLD, RS 2025-07-28
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219666-001 11072614 2038-04-16 U-4251 Drug substance 2025-08-26 N219666-001 11752154 2038-09-04 U-4251 Drug product 2025-08-26 N219666-001 12213982 2038-09-04 U-4251 2025-08-26 N219666-001 12257252 2042-03-06 U-4250 2025-08-26 N219666-002 11072614 2038-04-16 U-4251 Drug substance 2025-08-26 N219666-002 11752154 2038-09-04 U-4251 Drug product 2025-08-26 N219666-002 12213982 2038-09-04 U-4251 2025-08-26 N219666-002 12257252 2042-03-06 U-4250 2025-08-26
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219666-001 SEPHIENCE 250MG/PACKET POWDER / ORAL RLD 2025-07-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219666-002 SEPHIENCE 1GM/PACKET POWDER / ORAL RLD, RS 2025-07-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-001 SEPHIENCE 250MG/PACKET POWDER / ORAL RLD 2025-07-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-002 SEPHIENCE 1GM/PACKET POWDER / ORAL RLD, RS 2025-07-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219666-001 SEPHIENCE 250MG/PACKET POWDER / ORAL RLD 2025-07-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219666-002 SEPHIENCE 1GM/PACKET POWDER / ORAL RLD, RS 2025-07-28 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-001 SEPHIENCE 250MG/PACKET POWDER / ORAL RLD 2025-07-28 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-002 SEPHIENCE 1GM/PACKET POWDER / ORAL RLD, RS 2025-07-28 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219666-001 11072614 2038-04-16 U-4251 Drug substance 2025-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219666-001 11752154 2038-09-04 U-4251 Drug product 2025-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219666-001 12213982 2038-09-04 U-4251 2025-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219666-001 12257252 2042-03-06 U-4250 2025-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219666-002 11072614 2038-04-16 U-4251 Drug substance 2025-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219666-002 11752154 2038-09-04 U-4251 Drug product 2025-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219666-002 12213982 2038-09-04 U-4251 2025-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219666-002 12257252 2042-03-06 U-4250 2025-08-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-001 11072614 2038-04-16 U-4251 Drug substance 2025-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-001 11752154 2038-09-04 U-4251 Drug product 2025-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-001 12213982 2038-09-04 U-4251 2025-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-001 12257252 2042-03-06 U-4250 2025-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-002 11072614 2038-04-16 U-4251 Drug substance 2025-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-002 11752154 2038-09-04 U-4251 Drug product 2025-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-002 12213982 2038-09-04 U-4251 2025-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-002 12257252 2042-03-06 U-4250 2025-08-26 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-001 11072614 2038-04-16 U-4251 Drug substance 2025-08-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-001 11752154 2038-09-04 U-4251 Drug product 2025-08-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-001 12213982 2038-09-04 U-4251 2025-08-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-001 12257252 2042-03-06 U-4250 2025-08-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-002 11072614 2038-04-16 U-4251 Drug substance 2025-08-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-002 11752154 2038-09-04 U-4251 Drug product 2025-08-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-002 12213982 2038-09-04 U-4251 2025-08-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-002 12257252 2042-03-06 U-4250 2025-08-26 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219666-001 NCE 2030-07-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219666-002 NCE 2030-07-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-001 NCE 2030-07-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219666-002 NCE 2030-07-28 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-001 NCE 2030-07-28 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-001 ODE-542 2032-07-28 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-002 NCE 2030-07-28 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219666-002 ODE-542 2032-07-28 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Documents# Document, Submission type, Date table Document Submission type Date 83247 ORIG 2025-09-02 82983 ORIG 2025-07-29 82972 ORIG 2025-07-29